VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.98 Cr | ₹2.49 Cr | ₹2.44 Cr | ₹3.14 Cr | ₹2.82 Cr |
What is the latest Contingent Liabilities ratio of VIMTA LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2024 | ₹4.98 Cr |
| Mar2023 | ₹2.49 Cr |
| Mar2022 | ₹2.44 Cr |
| Mar2021 | ₹3.14 Cr |
| Mar2020 | ₹2.82 Cr |
How is Contingent Liabilities of VIMTA LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹4.98 Cr | 100.12 | |
| Mar2023 | ₹2.49 Cr | 1.97 | |
| Mar2022 | ₹2.44 Cr | -22.22 | |
| Mar2021 | ₹3.14 Cr | 11.16 | |
| Mar2020 | ₹2.82 Cr | - | |
Compare Contingent Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,428.9 Cr | -6% | -9.8% | 20.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -6% |
-9.8% |
20.4% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses